Mahar

India, the fourth worst hit nation by the coronavirus, reported a total of 456,183 infections and 14,476 deaths on Wednesday Hyderabad-based drug maker Hetero, which has approval to manufacture and market generic version of Remdesivir, has sent 20,000 vial of the COVID-19 drug to five states, including Maharashtra and Delhi - the two worst affected states in the country. Gujarat and Tamil Nadu are the other two states that will receive the first batch of the experimental COVID-19 drug. Telangana's capital city Hyderabad, where the drugmaker is based, will also receive the first consignment of the drug which is being…